Purification, modeling, and analysis of botulinum neurotoxin subtype a5 (BoNT/A5) from Clostridium botulinum strain A661222

Applied and Environmental Microbiology

Volumn 77, Issue 12, 2011, Pages 4217-4222

  Jacobson, Mark J ^a   Lin, Guangyun ^a   Tepp, William ^a   Dupuy, Jerome ^b   Stenmark, Pål ^b,c   Stevens, Raymond C ^b   Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID CHAINS; BOTULINUM NEUROTOXINS; CLOSTRIDIUM BOTULINUM; CULTURE COLLECTION; DEGREE OF SIMILARITY; HEAVY CHAIN;

AMINO ACIDS; ANTIBODIES; CLOSTRIDIUM; GENES; PURIFICATION;

CRYSTAL STRUCTURE;

ANTITOXIN; BACTERIAL DNA; BACTERIUM ANTIBODY; BOTULINUM TOXIN A; NEUTRALIZING ANTIBODY;

AMINO ACID; ANTIBODY; BACTERIUM; CRYSTAL STRUCTURE; GENETIC ANALYSIS; HOMOGENEITY; MOLECULAR ANALYSIS; NEUTRALIZATION; NUMERICAL MODEL; PURIFICATION; TOXIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLOSTRIDIUM BOTULINUM; DNA SEQUENCE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENY; SEQUENCE HOMOLOGY; SERODIAGNOSIS;

ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTITOXINS; BOTULINUM TOXINS, TYPE A; CLOSTRIDIUM BOTULINUM; DNA, BACTERIAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID;

CLOSTRIDIUM BOTULINUM;

EID: 79960085306     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00201-11     Document Type: Article

References (19)

1. Arnon, S. S., et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070.
2. Atassi, M. Z., and B. Z. Dolimbek. 2004. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A. Protein J. 23:39-52.
3. Carter, A. T., et al. 2009. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 10:115.
4. DasGupta, B. R., and V. Sathyamoorthy. 1984. Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 22:415-424.
5. Delano, W. L. The PyMOL molecular graphics system. DeLano Scientific LLC, San Carlos, CA.
6. Dineen, S. S., M. Bradshaw, and E. A. Johnson. 2003. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications. Curr. Microbiol. 46:345-352.
7. Dolimbek, B. Z., K. R. Aoki, L. E. Steward, J. Jankovic, and M. Z. Atassi. 2007. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol. Immunol. 44:1029-1041.
8. Dover, N., J. R. Barash, and S. S. Arnon. 2009. Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol. 47:2349-2350.
9. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60:2126-2132.
10. Garcia-Rodriguez, C., et al. 2007. Molecular evolution of antibody crossreactivity for two subtypes of type A botulinum neurotoxin. Nat. Biotechnol. 25:107-116.
11. Hill, K. K., et al. 2007. Genetic diversity among botulinum neurotoxinproducing clostridial strains. J. Bacteriol. 189:818-832.
12. Jacobson, M. J., G. Lin, B. Raphael, J. Andreadis, and E. A. Johnson. 2008. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl. Environ. Microbiol. 74:2778-2786.
13. Lacy, D. B., and R. C. Stevens. 1999. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291:1091-1104.
14. Lacy, D. B., W. Tepp, A. C. Cohen, B. R. DasGupta, and R. C. Stevens. 1998. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:898-902.
15. Pier, C. L., et al. 2011. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett. 585:199-206.
16. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
17. Smith, T. J., et al. 2005. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 73: 5450-5457.
18. Stenmark, P., J. J. Dupuy, A. Imamura, M. Kiso, and R. C. Stevens. 2008. Crystal structure of botulinum neurotoxin type A in complex with the cell surface coreceptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog. 4:e1000129.
19. Zarebski, L. M., et al. 2008. Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Rev. Vaccines 7:55-74.